A special report published in the Association for Diagnostics & Laboratory Medicine’s The Journal of Applied Laboratory Medicine describes the design, operations, and methodology of the COVID Immunity Study, a large-scale scientific study by ADLM that took place in September 2021.
A special report on the study’s design published in ADLM’s The Journal of Applied Laboratory Medicine
WASHINGTON, Dec. 7, 2023 /PRNewswire/ -- A special report published today in the Association for Diagnostics & Laboratory Medicine‘s (ADLM’s, formerly AACC’s) The Journal of Applied Laboratory Medicine describes the design, operations, and methodology of the COVID Immunity Study, a large-scale scientific study by ADLM that took place in September 2021. By detailing the design of this novel study, the special report aims to facilitate similar studies by other scientific societies. These could fill in gaps in infectious disease research and potentially improve the global response to future pandemics.
View the full report here: https://academic.oup.com/jalm/advance-article/doi/10.1093/jalm/jfad089/7416439
The COVID Immunity Study is the first scientific study performed by a professional association that combines an online health survey, on-site blood collection, off-site testing and analysis, provision of SARS-CoV-2 testing results to participants, and sample banking to address questions of SARS-CoV-2 immunity. Large-scale epidemiological studies such as this are crucial for understanding how viruses evolve and for making informed public health decisions. Because these types of studies demand tremendous resources, they are typically conducted by government agencies or as collaborative efforts by academic research groups. As the COVID Immunity Study shows, though, scientific societies also have the resources and expertise to perform large-scale epidemiological studies. These organizations are also in a position to investigate potentially important lines of inquiry that traditionally funded research can’t look into. While several papers that were either recently published or in preparation focus on the results of the COVID Immunity Study, this special report discusses the methodology of the study and unique challenges it encountered with the goal of providing a model for other scientific societies to follow.
The COVID Immunity Study was mainly conducted at the 2021 AACC Annual Scientific Meeting in Atlanta. Blood was drawn on-site from 698 participants, who provided consent and completed general health and COVID-19 questionnaires beforehand. A portion of each sample was sent to Quest Diagnostics for T-cell function analysis, while serum and plasma were obtained from the remaining samples, which were stored at Centers for Disease Control and Prevention (CDC) facilities in Atlanta and made available to medical and research communities. Partnerships between ADLM staff and subject-matter experts such as clinical laboratory scientists and immunologists, as well as state and local health departments, were crucial to the success of the study.
The study group encountered several logistical and practical challenges during the execution of the COVID Immunity Study, including staffing shortages due to the pandemic, the lack of prior on-site facilities for a scientific study, unavailable and back-ordered supplies, and the large number of participants required to donate blood. Though the COVID Immunity Study was successfully planned and executed in 6 months, the paper’s authors recommend a 12-month or longer period for such a study, especially if conducted in pandemic conditions.
“ADLM believes that the unique makeup of scientific societies positions them well to ask and answer pressing questions in their fields that might otherwise not fall into a clear area of interest by traditional research funding sources,” the report authors said. “We hope that this paper will serve as a reference — and set a precedent — for member-based organizations to contribute to future such scientific studies.”
About the Association for Diagnostics & Laboratory Medicine (ADLM)
Dedicated to achieving better health through laboratory medicine, ADLM (formerly AACC) brings together more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from around the world focused on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other areas of progressing laboratory science. Since 1948, ADLM has worked to advance the common interests of the field, providing programs that advance scientific collaboration, knowledge, expertise, and innovation. For more information, visit www.myadlm.org.
The Journal of Applied Laboratory Medicine (academic.oup.com/jalm) is published online by ADLM. This international, peer-reviewed publication showcases applied research on clinically relevant laboratory topics as well as commentary on the practice of clinical chemistry and laboratory medicine.
Christine DeLong
ADLM
Senior Manager, Communications & PR
(p) 202.835.8722
cdelong@myadlm.org
Molly Polen
ADLM
Senior Director, Communications & PR
(p) 202.420.7612
(c) 703.598.0472
mpolen@myadlm.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/lessons-learned-from-adlms-covid-immunity-study-could-improve-research-on-future-pandemics-302009360.html
SOURCE Association for Diagnostics & Laboratory Medicine (ADLM)
